Venture Leaders
Vincent Forster and Mattias Ivarsson are among 20 candidates that have been selected for the Venture Leaders program.
Vincent and Mattias are among 20 candidates that have been selected for the
2014 external pageVenture Leaders program. They will take part in a 10-day entrepreneurship training camp in Boston and NYC as part of the Swiss national startup team.
Today, venturelab announces the names of the 20 young, promising entrepreneurs selected to join the Swiss National Startup Team. Selected out of 120 contenders, the 2014 Swiss National Startup Team will participate in the venture leaders program this June, flying to Boston and for the first time to New York. The venture leaders program offers global potential Swiss startups with a 10-day business development training based in the US.
Vincent Forster, Versantis – Biotech (www.versantis.ch)
Versantis is developing versatile antidotes, capable of removing diverse toxic agents from the organism and save patients from metabolic, medicine and drug overdoses.
Mattias Ivarsson,Inositec – Biotech (no website)
Inositec will pursue the preclinical and early clinical development of a novel non-antibiotic treatment against Clostridium difficile infection. Clostridium difficile is the leading cause of potentially deadly gastro-intestinal infections caused by antibiotic treatment in healthcare settings.